Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy

Robert Hermans(Universitair Ziekenhuis Leuven), Philippe Lambin(Maastricht University Medical Centre), Martijn R. Meijerink(Amsterdam University Medical Centers), Caroline Weltens(KU Leuven), A. Rijnders(KU Leuven), Walter Van den Bogaert(Radboud University Nijmegen)
International Journal of Radiation Oncology*Biology*Physics
November 20, 2003
10.1016/s0360-3016(03)00764-8
Cited by 185

Related Papers

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
|Journal of Clinical Oncology|2007|1k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
|New England Journal of Medicine|2001|950
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
|The Lancet Oncology|2014|679
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
|Journal of Clinical Oncology|2011|609